Understanding HIV/STD Risk and Enhancing PrEP Implementation Messaging in a Diverse Community-Based Sample of Gay, Bisexual, and Other Men Who Have Sex with Men in a Transformational Era
- Institution
- Emory University, GA
- Principal investigator
- Patrick Sean Sullivan
- Funding
- $1.5M
- Duration
- 2022–2026
Moonbase score
Still being scored
Abstract
Abstract The prevention of HIV in the United States is in a transformational era. In just a decade since the first finding of efficacy for daily oral PrEP, there is a proliferation of new PrEP agents, including long-acting injectable PrEP, and regimens, including “event-driven” (also called 2-1-1) PrEP. There has also been new knowledge about the impact of antiretrovirals (ARVs) for treatment of HIV, and an emergent understanding that people living with HIV who take ARVs and maintain a suppressed viral load are incapable of transmitting HIV to their sexual partners. In this context, the idea of “protected” sex – which historically meant sex protected by condoms – has become much more complex. To understand men’s preferences for prevention products and strategies and what choices are being made by men with varying risk profiles, we will enroll a prospective cohort of 1275 of men who have sex with men (MSM) in Atlanta, Detroit and San Diego and follow the cohort for two years. Each participant will have 8 quarterly quantitative assessments, including discreet choice experiments; a subset of MSM will be engaged in a qualitative assessments (focus group discussions and individual in-depth interviews) to help with message development and refinement. HIV and STI testing will be provided in alternating 6-month windows. Rapid reporting of results will produce actionable reports following each assessment wave. This project will serve as a dynamic source of data about the evolving patterns of use and preference for PrEP among MSM.
LOADING MOONBASE SCORE
Questions for Emory University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Emory University70
Mapping the blood cancer exposome for environmental risk profiles of mature B-cell neoplasms
Douglas Ian Walker · $545K · 2022–2027
- NIH · Emory University69
Learning to Predict Delayed Cerebral Ischemia with Novel Continuous Cerebral Arterial State Index
Xiao Hu · $617K · 2020–2026
- NIH · Emory University66
Fibrin-CAR-T cells therapies to enhance efficacy in glioblastoma treatments
Edikan Ogunnaike · $249K · 2022–2028